National Emphysema/COPD Association Company Profile

04:18 EST 22nd November 2017 | BioPortfolio

News Articles [1289 Associated News Articles listed on BioPortfolio]

GSK gets EU go-ahead for triple therapy inhaler in COPD

The EMA has awarded EU marketing authorisation to GlaxoSmithKline and Innovia’s single inhaler triple therapy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the treatment of chron...

Exposure to Disinfectants Linked to COPD

There is an association between the regular use of cleaning products and the development of COPD, an analysis of data from the Nurses' Health Study II shows. Medscape Medical News

National Plan for COPD Care

The final version of a coordinated nationwide plan to address chronic obstructive pulmonary disease (COPD), the third leading cause of death in the United States, was unveiled last month by the Nation...

Health Tip: Understanding COPD

-- Chronic obstructive pulmonary disease (COPD) is the third-leading cause of death in the United States, affecting some 16 million Americans and potentially millions more who don't know they have it....

Fluticasone Furoate, Umeclidinium, and Vilanterol Inhalation Powder (Trelegy Ellipta)

Trelegy Ellipta is indicated for the long-term maintenance treatment of patients with COPD, including chronic bronchitis and/or emphysema.

BIO, industry groups favor APHIS' withdrawal of biotech proposal

BIO and other industry groups such as the American Seed Trade Association, National Association of Wheat Growers and National -More- 

ME Association Petition: The NICE guideline for CFS/ME is not fit for purpose… | 10 July 2017

The ME Association has today launched a national petition that aims to demonstrate to NICE (National Institute for Health and Care Excellence) that people with CFS/ME are not happy with...

Opioids a Threat to Seniors With COPD

THURSDAY, July 6, 2017 -- Seniors with COPD -- a progressive lung disease that causes breathing problems -- may increase their odds for heart-related death if they use opioid painkillers, a new study ...

Drugs and Medications [268 Associated Drugs and Medications listed on BioPortfolio]

Spiriva [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use SPIRIVA HandiHaler safely and effectively. See full prescribing information for SPIRIVA HandiHaler. SPIRIVA HandiHaler (tiotropium bro...

Spiriva [Boehringer Ingelheim Pharmaceuticals Inc.]

These highlights do not include all the information needed to use SPIRIVA HandiHaler safely and effectively. See full prescribing information for SPIRIVA HandiHaler. SPIRIVA HandiHaler (tiotropium bro...

Isoxsuprine hydrochloride [Bi-Coastal Pharmaceutical Corporation]

Isoxsuprine Hydrochloride Tablets, USP

Monk [National Towelette Company ]

Image of Label

Instant hand sanitizer foam [National Distribution & Contracting, Inc.]

Drug Facts

PubMed Articles [2869 Associated PubMed Articles listed on BioPortfolio]

ADRB2 gene polymorphism and emphysema heterogeneity can modulate bronchodilator response in patients with emphysema.

Genetic variation in the β2-adrenergic receptor (ADRB2) gene has been thought to have an important role in the differential response to β2-agonist therapy for asthma. However, previous studies have ...

Quantifying the 'Lung at Risk' in COPD: Does Emphysema Beget Emphysema?

Emphysematous Phenotype is Characterized by Low Blood Eosinophils: A Cross-Sectional Study.

Sputum and blood eosinophils are proposed as candidate biomarkers for the identification of chronic obstructive pulmonary disease (COPD) patients at risk for exacerbation and treatment response. In th...

Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production.

Chronic obstructive pulmonary disease (COPD) is characterized by irreversible airflow obstruction and pulmonary emphysema. Persistent inflammation and remodeling of the lungs and airways result in red...

Matrix Metalloproteinase-28 Is a Key Contributor to Emphysema Pathogenesis.

Chronic obstructive pulmonary disease (COPD) comprises chronic bronchitis and emphysema, and is a leading cause of morbidity and mortality. Because tissue destruction is the prominent characteristic o...

Clinical Trials [3482 Associated Clinical Trials listed on BioPortfolio]

Assessment of Emphysema Using 1.5T MRI With UTE Pulse Sequences

Emphysema is a major pathological feature of Chronic Obstructive Pulmonary Disease (COPD). Non-invasive assessment of emphysema is a crucial issue for the phenotype and follow-up of COPD p...

Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap

The purpose of this cross-sectional, observational study is to evaluate the site and mechanism(s) for expiratory airflow limitation in chronic, treated, current or former smokers (>15 pack...

Biomarkers and Genetic Factors Related to Emphysema

Emphysema, a common type of chronic obstructive pulmonary disease (COPD), is a long-term lung disease that is usually caused by cigarette smoking. This study will examine both current smok...

Bronchoscopic EmphysemA Treatment in THE NetherLands

Rationale: New bronchoscopic treatments for emphysema have shown promise in clinical trials, improving lung function, exercise capacity and possibly survival and are now being adopted by a...

TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)

This 2 arm study will investigate the efficacy, safety and tolerability of RAR Gamma versus placebo in ex-smokers with moderate or severe emphysema treated with optimal COPD therapy. Follo...

Companies [2196 Associated Companies listed on BioPortfolio]

National Emphysema/COPD Association

COPD Foundation

Chronic Obstructive Pulmonary Disease (COPD) is the fourth leading cause of death in the U.S. and the only chronic disease growing in mortality. It affects approximately 24 millio...

Theron Pharmaceuticals, Inc.

Headquartered in Sunnyvale, California, Theron Pharmaceuticals is committed to developing improved treatments for COPD and asthma. COPD is a slowly developing progressive small ai...

Hunter Immunology Limited

Our lead product is a vaccine currently called HI-164OV. It works by controlling bacterial colonisation of airways damaged by inhaled toxins. It has been developed to treat patients with Chronic O...

Uptake Medical Corp.

Uptake Medical(TM) Corp. is a developer of medical technologies for the treatment of lung diseases including emphysema. The core technology is a simple, minimally invasive, non-implant interventional ...

More Information about "National Emphysema/COPD Association" on BioPortfolio

We have published hundreds of National Emphysema/COPD Association news stories on BioPortfolio along with dozens of National Emphysema/COPD Association Clinical Trials and PubMed Articles about National Emphysema/COPD Association for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of National Emphysema/COPD Association Companies in our database. You can also find out about relevant National Emphysema/COPD Association Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record